Corium International
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Business Model:
Revenue: $0
Employees: 501-1,000
Industries / Tags:
Detailed Corium International Information
Corium International was acquired by
Gurnet Point Capital.
The acquisition happend on 2018-10-11.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Menlo Park
State: California
Zip:
Country: United States
Financial Info
Stage:
debt financing
Raised Last:
$235M
Raised Total:$320M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.
Contact Phone:
Contact Email:
Corium International went public on 4/3/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/3/2014
Ticker Symbol:
CORI
IPO Price:
$8/share
Amount Raised:
$52M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2007 | Series C | 3 | $40M |
Essex Woodlands Healthcare Partners Aphelion Capital Quantum Technology Partners Essex Woodlands Healthcare Partners Aphelion Capital Quantum Technology Partners |
9/2021 | Debt Financing | 1 | $235M |
Hercules Capital Hercules Capital |
12/2012 | Convertible Note | 1 | $45M |
CRG CRG |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2007 | StrataGent Life Sciences |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
